1. Home
  2. TZOO vs RCEL Comparison

TZOO vs RCEL Comparison

Compare TZOO & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TZOO
  • RCEL
  • Stock Information
  • Founded
  • TZOO 1998
  • RCEL N/A
  • Country
  • TZOO United States
  • RCEL United States
  • Employees
  • TZOO 223
  • RCEL N/A
  • Industry
  • TZOO Advertising
  • RCEL Medical/Dental Instruments
  • Sector
  • TZOO Consumer Discretionary
  • RCEL Health Care
  • Exchange
  • TZOO Nasdaq
  • RCEL Nasdaq
  • Market Cap
  • TZOO 200.8M
  • RCEL 308.6M
  • IPO Year
  • TZOO 2002
  • RCEL N/A
  • Fundamental
  • Price
  • TZOO $17.01
  • RCEL $9.75
  • Analyst Decision
  • TZOO Strong Buy
  • RCEL Buy
  • Analyst Count
  • TZOO 3
  • RCEL 5
  • Target Price
  • TZOO $25.00
  • RCEL $17.25
  • AVG Volume (30 Days)
  • TZOO 137.6K
  • RCEL 186.1K
  • Earning Date
  • TZOO 02-25-2025
  • RCEL 02-13-2025
  • Dividend Yield
  • TZOO N/A
  • RCEL N/A
  • EPS Growth
  • TZOO 38.38
  • RCEL N/A
  • EPS
  • TZOO 1.06
  • RCEL N/A
  • Revenue
  • TZOO $84,373,000.00
  • RCEL $64,251,000.00
  • Revenue This Year
  • TZOO $3.00
  • RCEL $62.11
  • Revenue Next Year
  • TZOO $14.48
  • RCEL $31.19
  • P/E Ratio
  • TZOO $16.19
  • RCEL N/A
  • Revenue Growth
  • TZOO 2.97
  • RCEL 28.14
  • 52 Week Low
  • TZOO $7.12
  • RCEL $7.51
  • 52 Week High
  • TZOO $24.85
  • RCEL $18.93
  • Technical
  • Relative Strength Index (RSI)
  • TZOO 33.04
  • RCEL 50.10
  • Support Level
  • TZOO $20.41
  • RCEL $8.37
  • Resistance Level
  • TZOO $24.85
  • RCEL $11.25
  • Average True Range (ATR)
  • TZOO 1.40
  • RCEL 0.55
  • MACD
  • TZOO -0.48
  • RCEL 0.22
  • Stochastic Oscillator
  • TZOO 1.38
  • RCEL 47.92

About TZOO Travelzoo

Travelzoo acts as a publisher of travel and entertainment offers. It operates in four segments. Travelzoo North America segment consists of operations in Canada and the U.S.; Travelzoo Europe segment consists of operations in France, Germany, Spain, and the U.K.; and Jack's Flight Club segment consists of subscription revenue from premium members to access and receive flight deals from Jack's Flight Club via email or via Android or Apple mobile applications; New Initiatives consists of Travelzoo's licensing activities in Asia Pacific territories. It derives its revenue through advertising fees including listing fees paid by travel, entertainment, and local businesses to advertise their offers on the company's media properties. Most of the company's revenue is derived from North America.

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the US with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

Share on Social Networks: